Related Experiment Video

Updated: May 30, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

[Treatment strategy for patients with extracardiac structural anomalies and congenital heart disease]

Arata Murakami1

  • 1Department of Cardiac Surgery, University of Tokyo, Tokyo, Japan.

Nihon Geka Gakkai Zasshi
|August 9, 2011
PubMed

Insights

Treating complex congenital heart disease with extracardiac anomalies requires early, collaborative planning. Multidisciplinary conferences involving all specialists are crucial for improving surgical outcomes in these high-risk pediatric patients.

Area of Science:

  • Pediatric Surgery
  • Congenital Heart Surgery
  • Neonatology

Context:

  • Surgical treatment for patients with co-occurring extracardiac structural anomalies and congenital heart disease presents significant challenges and risks.
  • Effective management necessitates early development of comprehensive treatment plans.
  • Close collaboration and information exchange between pediatric surgery and congenital heart surgery teams are essential.

Purpose:

  • To review the historical advancements in congenital heart disease surgery and the evolution of the Japan Congenital Cardiovascular Surgery Database.
  • To highlight the critical role of neonatologists in the management hierarchy.
  • To illustrate the complexities of treating combined conditions, using a case of biliary atresia with hypoplastic left heart syndrome.

Summary:

  • The article emphasizes the importance of preoperative multidisciplinary conferences for optimizing surgical outcomes in complex pediatric cases.
  • It details the National Quality Forum's quality measures for congenital heart surgery, including structural, process, and outcome measures.
  • A case study of a patient with biliary atresia and hypoplastic left heart syndrome demonstrates effective intelligence sharing during treatment.

Impact:

  • Improved patient outcomes through enhanced preoperative planning and interdisciplinary communication.
  • Establishes a framework for managing high-risk pediatric surgical patients with complex congenital conditions.
  • Provides insights into the value of collaborative care models and quality measurement in pediatric cardiovascular surgery.

More Related Videos

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure07:41

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...